Loading stock data…
Genenta Science S.p.A. (GNTA)
$0.99+0.03 (+3.23%)
Market ClosedLast close Sep 8
Genenta Science S.p.A., a clinical-stage biotechnology company, develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Genenta Science S.p.A. in the Healthcare sector is trading at $0.99 with a market capitalization of $63M. The stock is currently near its 52-week low of $0.55, remaining 18.1% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 34) — potential for technical mean-reversion
Macro-economic sensitivity to interest rate and inflation shifts
Annual Financials
| Metric (USD) · Annual | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — |
| Operating Income | -$11.04M↑ | -$11.73M↓ | -$9.76M↓ | -$6.60M |
| Net Income | -$8.48M↑ | -$11.65M↓ | -$8.91M↓ | -$6.53M |
Peer Comparison
JNJUNHPFE
Fundamentals
Genenta Science S.p.A., a clinical-stage biotechnology company, develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company offers Temferon, which is in Phase 1/2a clinical trials for use in the treatment o...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$62.90M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.77
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-
Volume
Today's trading volume
36,385
Recent News
European Equities Traded in the US as American Depositary Receipts Decline Friday
European equities traded in the US as American depositary receipts were lower on Friday morning, she
European Equities Traded in the US as American Depositary Receipts Higher Tuesday
European equities traded in the US as American depositary receipts were rising Tuesday morning, up 1
Genenta Science SPA (GNTA) Shifting from Biotech to Defense Business
Genenta Science SPA (NASDAQ:GNTA) is among the best Italian stocks to buy in 2026. Genenta Science SPA (NASDAQ:GNTA) will hold an extraordinary shareholders meeting on March 26. This comes on the back of the company announcing a major shift in its business strategy. Genenta Science, which has all along been concentrating on biotech programs with […]
European Equities Traded in the US as American Depositary Receipts Gain Friday
European equities traded in the US as American depositary receipts were rising on Friday morning, up
US-China Trade Optimism Lifts US Equity Futures Pre-Bell
US equity futures were up ahead of Monday's opening bell as traders monitored developments surroundi